Mixtard 30/70 (Human Insulin) Vials in Kenya: Product Description

Product Overview

Mixtard 30/70 is a biphasic human insulin suspension containing:

• 30% soluble insulin (rapid-acting) for mealtime coverage.
• 70% isophane insulin (NPH) (intermediate-acting) for basal coverage.

It is used to manage type 1 and type 2 diabetes in adults and children requiring insulin therapy. In Kenya, Mixtard vials are a cost-effective option for daily insulin needs, available in government hospitals and major pharmacies.

Key Benefits:

• Dual-action: Controls post-meal glucose spikes + provides overnight coverage.
• Proven safety profile (human insulin, not analog).
• Affordable compared to modern insulin analogs.

Frequently Asked Questions (FAQs)

1. What is Mixtard 30/70 used for?

   • Type 1 Diabetes: Basal-bolus therapy (combined with rapid-acting insulin).
   • Type 2 Diabetes: When oral medications fail to control blood glucose.
   • Not for: Diabetic ketoacidosis (use IV regular insulin).

2. Is Mixtard available in Kenya?

   • Yes, stocked in:
     • Government hospitals: Kenyatta National Hospital, Moi Teaching & Referral Hospital.
     • Major pharmacies: Goodlife, Medsafes, Cintas Pharma.
     • Diabetes clinics: Kenya Diabetes Management & Information Centre (KDMI).
   • Cost: ~KES 2,000–2,500 per 10ml vial (1,000 IU).

3. How is it stored?

   • Unopened: Refrigerate (2–8°C). Do not freeze.
   • Opened: Store below 30°C. Use within 6 weeks (discard if cloudy/clumped).

4. What are common side effects?

   • Hypoglycemia (low blood sugar): Sweating, shakiness, confusion.
   • Injection site reactions: Redness, swelling.
   • Lipodystrophy: Fat loss/thickening at injection sites (rotate sites).

5. Does NHIF cover Mixtard?

   • Yes, under NHIF’s “Supa Cover” for diabetes. Covers up to KES 10,000/year for insulin/syringes.

How to Use Mixtard 30/70

• Dosing:

  • Individualized: Based on blood glucose, diet, and activity.
  • Typical starting dose: 0.3–0.5 IU/kg/day (divided into 2 daily injections).
  • Timing: Inject 30 minutes before breakfast and dinner.

• Injection Technique:

  1. Roll vial gently between palms (do not shake).
  2. Draw air into syringe equal to insulin dose, inject into vial.
  3. Draw insulin into syringe, remove air bubbles.
  4. Inject subcutaneously into abdomen/thigh/arm.

• Critical Precautions:

  • Hypoglycemia Management: Always carry glucose tablets/sweet juice.
  • Rotate Sites: Prevent lipodystrophy (use abdomen, thighs, arms).
  • Never IV/IM: Subcutaneous only.
  • Alcohol: Increases hypoglycemia risk – limit intake.

Composition

• Active Ingredients per 1ml:
  • Human insulin (recombinant DNA origin): 100 IU.
  • Isophane (NPH) insulin: 70 IU.
  • Soluble insulin: 30 IU.
• Inactive Ingredients: Protamine sulfate, zinc chloride, glycerol, cresol.
• Packaging: 10ml vial (1,000 IU) with sterile syringes/needles.

Conclusion

Mixtard 30/70 remains a vital, accessible insulin for diabetes management in Kenya, offering reliable glucose control at an affordable cost. Its biphasic action simplifies therapy for patients requiring both basal and prandial coverage. Success hinges on:

• Consistent injection timing (30 mins before meals).
• Proper storage (refrigeration until opened).
• Regular blood glucose monitoring (fasting + post-meal).

Access & Support in Kenya:

1. NHIF Coverage:
   • Submit prescription + NHIF card at accredited pharmacies.
   • Co-pay: ~KES 500–1,000 per vial after reimbursement.
2. Cost-Saving Tips:
   • Government Hospitals: Free/subsidized insulin at KNH, Coast General Hospital.
   • Diabetes NGOs: KDMI offers free insulin education + subsidies.
3. Storage Solutions:
   • Use insulin cooler bags (KES 800–1,500) during travel/power outages.
   • Avoid direct sunlight/heat.

Disclaimer: Not medical advice. Consult an endocrinologist before starting insulin therapy.